TriPath Seeks Higher SurePath Sales Through Quest Agreement
This article was originally published in The Gray Sheet
Executive Summary
TriPath Imaging's plan to increase large labs' adoption of the SurePath liquid-based cervical cytology system includes a nonexclusive agreement with Quest Diagnostics